A. Helgeland

发表

VoluViz3.1 theory and user guide – a flexible volume visualization framework for 4D data analysis

A. Helgeland, 2015 .

The Oslo Study: diet and antismoking advice. Additional results from a 5-year primary preventive trial in middle-aged men.

I. Holme, I. Hjermann, A. Helgeland, 1985, Preventive medicine.

Numerical simulations of the pulsating flow of cerebrospinal fluid flow in the cervical spinal canal of a Chiari patient.

Kent-Andre Mardal, Bjørn Anders Pettersson Reif, Anders Helgeland, 2014, Journal of biomechanics.

Visualization of vector fields using Line Integral Convolution and volume rendering

A. Helgeland, 2002 .

HDL-cholesterol in antihypertensive treatment. The Oslo Study.

I. Holme, I. Hjermann, S. Enger, 2009, Acta medica Scandinavica. Supplementum.

The effect of dietary changes on high density lipoprotein cholesterol. The Oslo Study.

I. Holme, I. Hjermann, S. Enger, 1979, The American journal of medicine.

EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1980, The Lancet.

Risk Factors for Coronary and Cerebral Atherosclerosis in the Oslo Study

L. Solberg, J. Strong, I. Holme, 1980 .

Serum glucose levels during long-term observation of treated and untreated men with mild hypertension. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1984, The American journal of medicine.

Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes

U. Bergman, U. Rosenqvist, A. Wessling, 2004, European Journal of Clinical Pharmacology.

Therapeutic traditions in Northern Ireland, Norway and Sweden: II. Hypertension

U. Bergman, L. Wilhelmsen, U. Faire, 1986, European Journal of Clinical Pharmacology.

MRFIT and the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1983, Journal of the American Medical Association (JAMA).

Physical activity at work and at leisure in relation to coronary risk factors and social class. A 4-year mortality follow-up. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica.

Socio-economic status as a coronary risk factor: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica. Supplementum.

CORONARY RISK FACTORS AND SOCIOECONOMIC STATUS The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1976, The Lancet.

High density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study.

I. Holme, I. Hjermann, S. Enger, 1979, Artery.

Decreased peripheral dopaminergic activity in essential hypertension?

S. Kjeldsen, A. Helgeland, P. Leren, 1983, Scandinavian journal of clinical and laboratory investigation.

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study.

I. Holme, I. Hjermann, S. Enger, 1978, British medical journal.

Antihypertensive drugs and blood lipids: the Oslo study.

I. Holme, I. Hjermann, S. Kjeldsen, 1982, British journal of clinical pharmacology.

Possible metabolic side effects of beta-adrenergic blocking drugs.

I. Holme, I. Hjermann, A. Helgeland, 1978, British medical journal.

Antihypertensive Drugs and Blood Lipids: The Oslo Study

I. Holme, I. Hjermann, S. Kjeldsen, 1982, Journal of cardiovascular pharmacology.

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension. The Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1978, The American journal of medicine.

Treatment of Borderline and Mild Hypertension: The Oslo Study

I. Holme, I. Hjermann, A. Helgeland, 1981 .

Increased peripheral release of noradrenaline and uptake of adrenaline in essential hypertension?

S. Kjeldsen, A. Helgeland, P. Leren, 1981, Clinical science.

Evidence of increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.

S. Kjeldsen, A. Helgeland, P. Leren, 1982, Scandinavian journal of clinical and laboratory investigation.

The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study.

I. Holme, I. Hjermann, A. Helgeland, 2009, Acta medica Scandinavica.

ENALAPRIL, ATENOLOL, AND HYDROCHLOROTHIAZIDE IN MILD TO MODERATE HYPERTENSION A Comparative Multicentre Study in General Practice in Norway

S. Tretli, A. Helgeland, C. Hagelund, 1986, The Lancet.

The influence of atenolol and prazosin on serum lipids and atherosclerosis in minipigs fed a hyperlipidemic diet.

L. Solberg, A. Helgeland, I. Nafstad, 1988, General pharmacology.

The influence of prazosin and propranolol on serum lipids and atherosclerosis in standard fed pigs.

L. Solberg, A. Helgeland, I. Nafstad, 2009, Acta pharmacologica et toxicologica.

Patient reaction to information and motivation factors in long-term treatment with antihypertensive drugs.

A. Helgeland, I. Baksaas, 2009, Acta medica Scandinavica.

Mild hypertension--early drug treatment or follow-up only? The Oslo study.

A. Helgeland, P. Leren, I. B. Aasen, 2009, Acta medica Scandinavica. Supplementum.

[The Oslo study. 4-year mortality, coronary risk factors and socioeonomic indicators].

I. Holme, I. Hjermann, A. Helgeland, 1980, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

Increased peripheral catecholamine release in patients with long-standing, untreated essential hypertension.

S. Kjeldsen, A. Helgeland, P. Leren, 2009, Acta medica Scandinavica. Supplementum.

Treatment of mild hypertension with diuretics. The importance of ECG abnormalities in the Oslo Study and in MRFIT.

I. Holme, I. Hjermann, A. Helgeland, 1984, JAMA.

Effects of Thiazides on Lipid Metabolism

A. Helgeland, 1986 .

Changes in the lipoprotein profile during antihypertensive therapy.

S. Kjeldsen, A. Helgeland, P. Leren, 2009, Acta pharmacologica et toxicologica.

Oslo Hypertension Study

A. Helgeland, P. Leren, 2012, Drugs.

Correlates of blood pressure change in middle-aged male mild hypertensives: results from the untreated control group in the Oslo hypertension trial. The Oslo Study.

I. Holme, I. Hjermann, A. Helgeland, 1988, American journal of epidemiology.

Oslo Study: Treatment of Mild Hypertension

A. Helgeland, P. Leren, 1987 .

Coronary heart disease and treatment of hypertension. Some Oslo Study data.

A. Helgeland, P. Leren, 1986, The American journal of medicine.

Double-blind comparison of trimazosin and propranolol in essential hypertension.

A. Helgeland, 1983, American heart journal.

Treatment of hypertension with prazosin. An open study in general practice.

P. Fauchald, A. Helgeland, 2009, Acta medica Scandinavica. Supplementum.

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

A. Helgeland, 1980, The American journal of medicine.

Efficacy of face masks as source control and respiratory protection against transmission of SARS-CoV-2

M. Dybwad, Espen Åkervik, E. Fykse, 2021 .

TREATMENT OF BETA-BLOCKER POISONING

A. Helgeland, D. Jacobsen, B. Jones, 1980, The Lancet.

BETA-BLOCKER POISONING

A. Helgeland, D. Jacobsen, A. Koss, 1980, The Lancet.

The Oslo study. Cardiovascular disease in middle-aged and young Oslo men.

I. Holme, I. Hjermann, A. Helgeland, 1975, Acta medica Scandinavica. Supplementum.

Four and two-thirds years incidence of coronary heart disease in middle-aged men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, American journal of epidemiology.

Coronary risk factors and their pathway of action through coronary raised lesions, coronary stenoses and coronary death. Multivariate statistical analysis of an autopsy series: the Oslo Study.

L. Weissfeld, O. Williams, L. Solberg, 1985, The American journal of cardiology.

Visualization of the energy-containing turbulent scales

Trond Gaarder, Øyvind Andreassen, Anders Helgeland, 2004, 2004 IEEE Symposium on Volume Visualization and Graphics.

Serum insulin response to oral glucose load during a dietary intervention trial in healthy coronary high risk men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, Scandinavian journal of clinical and laboratory investigation.

Four-year mortality by some socioeconomic indicators: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1980, Journal of epidemiology and community health.

Coronary risk factors in various occupational groups: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1977, British journal of preventive & social medicine.

ENALAPRIL, ATENOLOL, AND HYDROCHLOROTHIAZIDE IN HYPERTENSION

P. Gøtzsche, S. Tretli, A. Helgeland, 1986, The Lancet.

[Coronary risk factors and socioeconomic status. The Oslo study].

I. Holme, I. Hjermann, A. Helgeland, 1977, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

The association between blood pressure and serum cholesterol in healthy men: the Oslo study.

I. Holme, I. Hjermann, A. Helgeland, 1978, Journal of epidemiology and community health.

Effect of craniovertebral decompression on CSF dynamics in Chiari malformation type I studied with computational fluid dynamics: Laboratory investigation.

V. Haughton, S. Linge, A. Helgeland, 2014, Journal of neurosurgery. Spine.

Effect of Tonsillar Herniation on Cyclic CSF Flow Studied with Computational Flow Analysis

V. Haughton, H. Langtangen, A. Helgeland, 2011, American Journal of Neuroradiology.

Simulating CSF Flow Dynamics in the Normal and the Chiari I Subarachnoid Space during Rest and Exertion

V. Haughton, S. Linge, A. Helgeland, 2013, American Journal of Neuroradiology.

Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study.

L. Solberg, J. Strong, I. Holme, 1985, Laboratory investigation; a journal of technical methods and pathology.

Computational fluid dynamics simulations of local wind in large urban areas

A. Helgeland, H. Fossum, 2020 .

Association between Risk Factors and Atherosclerotic Lesions Based on Autopsy Findings in the Oslo Study: A Preliminary Report

L. Solberg, J. Strong, I. Holme, 1977 .

Visualization of Vorticity and Vortices in Wall-Bounded Turbulent Flows

Carl Erik Wasberg, Øyvind Andreassen, Anders Helgeland, 2007, IEEE Transactions on Visualization and Computer Graphics.

Effect of craniovertebral decompression on CSF dynamics in Chiari malformation type I studied with computational fluid dynamics: Laboratory investigation.

V. Haughton, S. Linge, A. Helgeland, 2014, Journal of neurosurgery. Spine.

The Oslo study: CHD risk factors, socioeconomic influences, and intervention.

I. Holme, I. Hjermann, A. Helgeland, 1983, American heart journal.